Adipo Therapeutics
PrivateLast Round
Series A
May 9, 2025
Total Funding Raised
$6.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adipo Therapeutics operates in Healthcare & Life Sciences and is based in Indianapolis, Indiana. Its latest recorded funding round was a Grant round in June 2024.
Adipo Therapeutics is a biotechnology company developing a novel therapeutic platform that uses Notch-inhibiting nanoparticles to convert energy-storing white fat into energy-burning brown fat for the treatment of obesity and Type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adipo Therapeutics Comparables
Compare Adipo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Equator Therapeutics | 85% | |
| Energesis Pharmaceuticals, Inc. | 83% | |
| Cyta Therapeutics | 81% |
For institutional investors. Book with your work email.
Adipo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 9, 2025 | ||||
| Grant | Jun 24, 2024 | ||||
| Seed | Jan 31, 2024 | ||||
| Seed | Apr 11, 2023 | ||||
| Seed | Jan 11, 2022 | ||||
Grant | Sep 13, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adipo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed |
| State of Indiana | Grant |
| NIH RADx | Grant |
| VisionTech Partners | Seed |
| Purdue Innovates Ventures | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 51% MoM, reaching 2.2K.
- Jul 28, 2026
Monthly visitors increased 123% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
Adipo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adipo Therapeutics's valuation, stock price, and market status.
Is Adipo Therapeutics a public or private company?
Adipo Therapeutics is a private company.
What is the current stock price of Adipo Therapeutics?
Adipo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Adipo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adipo Therapeutics worth (valuation)?
Valuation information for Adipo Therapeutics is not publicly available.
Can I buy Adipo Therapeutics stock?
Adipo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adipo Therapeutics's last funding round?
Adipo Therapeutics's most recent funding round was Series A on May 9, 2025.
Who are the main investors in Adipo Therapeutics?
Key investors in Adipo Therapeutics include Purdue Research Foundation, Elevate Ventures, State of Indiana, NIH RADx, VisionTech Partners.
Will Adipo Therapeutics IPO soon?
No public IPO plans have been announced for Adipo Therapeutics.
How can I track Adipo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Adipo Therapeutics's shares on secondary markets.